Clinical Trials Directory

Trials / Completed

CompletedNCT05692648

Effect of Repositioning Frequency Neonates Receiving Phototherapy

Effect of Repositioning Frequency on Bilirubin Level and Infant Comfort in Neonates Receiving Phototherapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Selcuk University · Academic / Other
Sex
All
Age
35 Weeks – 42 Weeks
Healthy volunteers
Accepted

Summary

Purpose: The present study was conducted to determine the effect of repositioning frequency during phototherapy on bilirubin level and neonates comfort. Design and methods: This was a single-centered, single-blind, 3-arm, pretest-posttest parallel-group randomized controlled trial conducted in a neonatal intensive care unit. Participants were randomly assigned to one of three groups: Supine position group (n = 20), hourly position change group (n = 20), and control group (n = 20). The bilirubin level and comfort levels of the neonates were evaluated.

Detailed description

Purpose: The present study was conducted to determine the effect of repositioning frequency during phototherapy on bilirubin level and neonates comfort.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSupine position groupThese neonates were placed in supine position, fed every 2 hours in accordance with routine clinical practice, and then returned to supine position.
BEHAVIORALHourly position change groupInfants in this group were repositioned "every hour" based on the time of phototherapy initiation. Neonates were initially placed in supine position and then changed to the prone position. Infants were alternated between supine and prone positions every hour for 24 hours.
BEHAVIORALControl Group (2-hour position change)Neonates in this group were repositioned every 2 hours as routine practice based on the time of phototherapy initiation. Phototherapy was started with neonates in supine position. In the second period, the neonate was placed in the prone position after routine feeding was performed.

Timeline

Start date
2020-02-01
Primary completion
2020-08-30
Completion
2020-09-30
First posted
2023-01-20
Last updated
2023-01-20

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05692648. Inclusion in this directory is not an endorsement.